{"entity":{"type":"insider","cik":"0001469954","url":"/insider/0001469954","json_url":"/insider/0001469954.json","name":"Scarsdale Equities LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":3,"first":"2014-09-08","last":"2014-10-06","span_basis":"filed_date"},"name_variants":[{"name":"Scarsdale Equities LLC","source":"filing","n_filings":3,"first_seen":"2014-09-08","last_seen":"2014-10-06"}],"transactions":[{"id":7080277,"accession":"0001532199-14-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001532199-14-000008","line_url":"/filing/0001532199-14-000008#line-2","is_derivative":false,"issuer_cik":"0001469954","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"ASTY","issuer_name_source":null,"issuer_url":"/issuer/0001469954","owner_cik":"0001469954","owner_name":"Scarsdale Equities LLC","owner_display_name":"Scarsdale Equities LLC","owner_url":"/insider/0001469954","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Series A Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":5.9671,"price_display":"5.97","price_state":"stated","total_value":298355.0,"total_display":"298,355.00","total_whole":"298,355","shares_owned_after":886000.0,"shares_owned_after_display":"886,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-06","scope":"insider"},{"id":7080274,"accession":"0001532199-14-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001532199-14-000008","line_url":"/filing/0001532199-14-000008#line-1","is_derivative":false,"issuer_cik":"0001469954","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"ASTY","issuer_name_source":null,"issuer_url":"/issuer/0001469954","owner_cik":"0001469954","owner_name":"Scarsdale Equities LLC","owner_display_name":"Scarsdale Equities LLC","owner_url":"/insider/0001469954","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Series A Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.726,"price_display":"5.73","price_state":"stated","total_value":57260.0,"total_display":"57,260.00","total_whole":"57,260","shares_owned_after":836000.0,"shares_owned_after_display":"836,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-29","filed_date":"2014-10-06","scope":"insider"},{"id":6945998,"accession":"0001532199-14-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001532199-14-000007","line_url":"/filing/0001532199-14-000007#line-2","is_derivative":false,"issuer_cik":"0001469954","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"ASTY","issuer_name_source":null,"issuer_url":"/issuer/0001469954","owner_cik":"0001469954","owner_name":"Scarsdale Equities LLC","owner_display_name":"Scarsdale Equities LLC","owner_url":"/insider/0001469954","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Series A Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.3536,"price_display":"5.35","price_state":"stated","total_value":53536.0,"total_display":"53,536.00","total_whole":"53,536","shares_owned_after":826000.0,"shares_owned_after_display":"826,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-24","filed_date":"2014-09-25","scope":"insider"},{"id":6945995,"accession":"0001532199-14-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001532199-14-000007","line_url":"/filing/0001532199-14-000007#line-1","is_derivative":false,"issuer_cik":"0001469954","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"ASTY","issuer_name_source":null,"issuer_url":"/issuer/0001469954","owner_cik":"0001469954","owner_name":"Scarsdale Equities LLC","owner_display_name":"Scarsdale Equities LLC","owner_url":"/insider/0001469954","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Series A Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":4.5773,"price_display":"4.58","price_state":"stated","total_value":68659.5,"total_display":"68,659.50","total_whole":"68,660","shares_owned_after":816000.0,"shares_owned_after_display":"816,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-23","filed_date":"2014-09-25","scope":"insider"},{"id":6802891,"accession":"0001532199-14-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001532199-14-000006","line_url":"/filing/0001532199-14-000006#line-2","is_derivative":false,"issuer_cik":"0001469954","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"ASTY","issuer_name_source":null,"issuer_url":"/issuer/0001469954","owner_cik":"0001469954","owner_name":"Scarsdale Equities LLC","owner_display_name":"Scarsdale Equities LLC","owner_url":"/insider/0001469954","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Series A Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":5.4782,"price_display":"5.48","price_state":"stated","total_value":164346.0,"total_display":"164,346.00","total_whole":"164,346","shares_owned_after":806000.0,"shares_owned_after_display":"806,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-05","filed_date":"2014-09-08","scope":"insider"},{"id":6802887,"accession":"0001532199-14-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001532199-14-000006","line_url":"/filing/0001532199-14-000006#line-1","is_derivative":false,"issuer_cik":"0001469954","issuer_name":"Asterias Biotherapeutics, Inc.","issuer_ticker":"ASTY","issuer_name_source":null,"issuer_url":"/issuer/0001469954","owner_cik":"0001469954","owner_name":"Scarsdale Equities LLC","owner_display_name":"Scarsdale Equities LLC","owner_url":"/insider/0001469954","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Series A Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":3.9971,"price_display":"4.00","price_state":"stated","total_value":279797.0,"total_display":"279,797.00","total_whole":"279,797","shares_owned_after":776000.0,"shares_owned_after_display":"776,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-04","filed_date":"2014-09-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001572552","name":"Asterias Biotherapeutics, Inc.","url":"/issuer/0001572552","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2014-09-08","last_seen":"2014-10-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001469954","retrieved_at":"2026-08-26T00:17:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}